NewsRoom Articles - Page 148 of 226

ThursdayOct 28, 2021 9:30 am

Mental Health America Publishes Annual Mental Health Status Report

Mental Health America recently published its annual report on the status of mental health within the country. The report ranks the District of Columbia and the 50 states based on various mental health prevalence and access measures. This year’s top-three ranking states were Massachusetts, New Jersey and Pennsylvania, in that order. The bottom-three ranking states were Arizona, Idaho and Nevada, also in that order. In the past eight years, the state of Nevada has occupied the bottom position in six such annual reports. The state of South Carolina recorded the biggest increase over 2020’s overall ranking, moving from number 43…

WednesdayOct 27, 2021 9:30 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Is ‘One to Watch’

The Mydecine Innovations Group portfolio includes a robust portfolio of NCEs (New Chemical Entities) and medicines based on compounds found in psychedelics, including four lead clinical trial drug candidates, as well as digital health solutions Through an exclusive partnership with Applied Pharmaceutical Innovations, the company has access to a Health Canada Scheduled 1 Drugs and Substances Dealer’s License Mydecine has a five-year master collaboration research agreement with Johns Hopkins University to research novel psychedelic therapies for mental health and addiction disorders Research out of Johns Hopkins University has shown promising efficacy data using psilocybin as a smoking cessation treatment with…

WednesdayOct 27, 2021 9:30 am

Spain Opens ‘Crying Room’ in Attempt to Dispel Stigma Surrounding Mental Health

Data released by Spain’s government shows that more than 3,600 individuals died by suicide in the country in 2019. This makes suicide the second most common cause of death, the first being natural causes. To help ease the shame around seeking help for mental health issues, a space known as La Lloreria, or the Crying Room, uses signs that tells visitors that it’s okay to seek help when one is dealing with mental health challenges. In addition to the signs, the room features a corner that has phones and a list of individuals, including psychologists, that visitors can call if…

TuesdayOct 26, 2021 9:43 am

Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) Target Diabetes Tech

The world’s largest and most powerful tech companies –Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) – are targeting an opportunity in health care that’s just too big to ignore – diabetes. Almost a third of the entire U.S. population – more than 100 million people in this country alone – are living with diabetes or are at high risk for the disease. Diabetes makes it difficult for the body to process sugar (glucose) and can lead to serious health issues and death. With $1 of every $4 of health care costs in the U.S. now spent on…

TuesdayOct 26, 2021 9:30 am

Study Finds That Widespread Pain Increases Risk of Stroke, Dementia

A new study has found that widespread pain in the body caused by chronic pain conditions such as fibromyalgia increases an individual’s risk of dementia and stroke. For their study, the researchers analyzed health data for more than 2,000 second-generation participants in the Framingham Heart Study. Offspring-phase participants who enrolled for the study in the 1990s underwent an extensive checkup that included a detailed pain assessment, laboratory tests and a physical exam. After this initial assessment, they underwent re-examination every four years for signs of stroke, dementia or cognitive decline. The researchers found that since their initial checkups, 139 of…

MondayOct 25, 2021 9:30 am

Personalized Cancer Assessment Upon Diagnosis Could Greatly Aid Treatment Planning

Precision medicine involves understanding the genetic makeup of every patient’s disease and tumor before giving a diagnosis and beginning treatment while personalized medicine means recognizing that the same ailment can behave differently in different patients. A study conducted recently by researchers from the School of Medicine at UC San Diego and Moores Cancer Center at the University of California San Diego has found that carrying out genomic evaluations of advanced malignancies can help guide initial treatment. Their findings were published in “Genome Medicine.” Cancers are complex on a molecular level, with each type made up of a different combination of…

FridayOct 22, 2021 9:30 am

Study Finds Space Travel May Cause Brain Damage

A new study has found that spending too much time in space may cause brain damage. The study involved following a group of Russian cosmonauts who stayed on the International Space Station (“ISS”), which is orbiting 400 km from the planet’s surface. The study was conducted by researchers at the University of Gothenburg. Its findings were published in the “JAMA Neurology” scientific journal. Previous research has found that negative changes to the human body caused by spending long periods of time in space include altered bacterial flora in the gut, deteriorating vision, reduced bone mass and atrophic muscles. For their…

ThursdayOct 21, 2021 12:31 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announced Inclusion in AdvisorShares Psychedelics ETF; KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

Tryp announced its inclusion in the AdvisorShares Psychedelics ETF The company hopes that its participation will open it up to a more diverse shareholder base and broaden its life science exposure Tryp’s presentation at the KCSA Virtual Investor Conference will also be available for on-demand viewing over the next 90 days Launched back in September 2021, the AdvisorShares Psychedelics Exchange-Traded Fund (“ETF”) has been actively trading, focusing on enterprises that have devoted a significant proportion of their assets to psychedelic drug development. Operating under the ticker symbol “PSIL” on the New York Stock Exchange (“NYSE”) Arca exchange, this fund has…

ThursdayOct 21, 2021 9:48 am

OSA Predisposes People to Metabolic Defects, Study Finds

Obstructive sleep apnea ("OSA") predisposes individuals to type 2 diabetes and hyperglycemia, despite research showing that positive airway pressure doesn’t boost glucose dysregulation markers. This sleep disorder has been linked to impaired glucose disposal. During a recent presentation, University of Miami Miller School of Medicine’s chief of division of pulmonary, sleep medicine and critical care Naresh M. Punjabi stated that obstructive sleep apnea also impaired insulin and was linked to changes in free fatty acid kinetics. Punjabi explained that prior research had found that sleep apnea could speed up betacell compensation to insulin resistance, in addition to inducing insulin resistance.…

WednesdayOct 20, 2021 1:42 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Files Patent Application Amid ‘New Era’ of Psychedelic Medicine

Substances such as psilocybin, ketamine and LSD are edging into mainstream culture, setting the stage for a paradigm shift in modern medicine Cybin has filed an international patent application covering methods for the delivery of psychedelic medications by inhalation The company is pursuing the effectiveness of using inhalation as a delivery method for psychedelic medications Earlier this month, a Time magazine article reported on the “new era” of psychedelic medicine (https://ibn.fm/bfC3u). On the leading edge of this collective breakthrough is Cybin (NEO: CYBN) (NYSE American: CYBN), a company focused on progressing psychedelic therapeutics, addressing the mental health crisis and transforming the…